Prosecution Insights
Last updated: May 29, 2026
Application No. 18/571,974

1,3-BUTADIENE SYNTHESIS CATALYST, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING 1,3-BUTADIENE

Non-Final OA §103
Filed
Dec 19, 2023
Priority
Jul 29, 2021 — nonprovisional of PCTJP2021028199
Examiner
CAMPANELL, FRANCIS C
Art Unit
1771
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Toyo Tire Corporation
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
4m
Est. Remaining
82%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
639 granted / 876 resolved
+7.9% vs TC avg
Moderate +9% lift
Without
With
+9.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
17 currently pending
Career history
898
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
77.4%
+37.4% vs TC avg
§102
17.1%
-22.9% vs TC avg
§112
2.8%
-37.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 876 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions The examiner recognizes the selection of group I claims 1-6 without traverse on the response of 2/3/2026. Accordingly claims 1-6 are examined in this office action. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1 and 3-6 is/are rejected under 35 U.S.C. 103 as being unpatentable over Spannhoff (US 2016/0145171 A1). The examiner notes that the method of production does not itself limit a composition claim. Regarding claims 1 and 3-6 Spannhoff teaches a method of making butadiene from ethanol (abstract). The process uses a crystalline silica (zeolite, see abstract). The catalyst contains Zr (p 17) and Zn (p, 31-32, and 54). With a ratio of metal to Si 1:10 to 1:150, see p 16. The Zn is disposed on the catalyst by impregnation and/or ion exchange. See p 32. As such ZnO would be present.. This constitutes the Zn interacting with the silanol groups of the silica support. In a case where the claimed ranges overlap or lie inside ranges disclosed by the prior art a prima facie case of obviousness exists. See In re Wertheim, 541 F.2d 257,191 USPQ 90 (CCPA 1946), and MPEP 2144.05. The catalyst is made using the template agent ammonium hydroxide, see p 37. The The framework for the support is MFI type, see p 19 and claim 9. An orthosilicate and metal salt is used to make the catalyst, see p 66-68. Claim(s) 2 is/are rejected under 35 U.S.C. 103 as being unpatentable over Spannhoff (US 2016/0145171 A1) and Hodgkins (US 2022/0340435 A1). Spannhoff does not specifically state the size of the micropores of the MFI type catalyst. Hodgkins teaches a zeolite catalyst of MFI framework (abstract). The catalyst has micropores and mesopores. The micropores have a pore size of 2 nm or less, see p 98. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the micropore size and volume as taught in Hodgkins in the invention of Spannhoff. They both use MFI type catalysts with micropores. The size and volume of the pores as taught in Hodgkins has the advantage of creating an effective MFI type catalyst. In the alternative Hodgkins provides evidence that an obvious variant of the MFI catalyst of Spannhoff is one with the micropore volume/size as taught. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to FRANK C CAMPANELL whose telephone number is (571)270-3165. The examiner can normally be reached Monday-Friday 9:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Prem Singh can be reached at 571-272-6381. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /FRANCIS C CAMPANELL/Examiner, Art Unit 1771 /PREM C SINGH/Supervisory Patent Examiner, Art Unit 1771
Read full office action

Prosecution Timeline

Dec 19, 2023
Application Filed
Mar 09, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635688
PROCESS AND SOLUTION FOR PREPARING A SURFACE WITH BACTERIOSTATIC AND BACTERICIDAL ACTIVITY, SURFACE THUS PREPARED AND USES THEREOF
3y 6m to grant Granted May 26, 2026
Patent 12637627
FORMULATIONS AND METHODS TO REMOVE NON-ACIDIC SULFUR COMPOUNDS FROM GAS STREAMS
2y 7m to grant Granted May 26, 2026
Patent 12630776
FUEL ADDITIVE COMPOSITION
1y 8m to grant Granted May 19, 2026
Patent 12624795
HYDROGEN GAS STORAGE TANKS WITH GRAPHYNE-CONTAINING LAYERS
2y 4m to grant Granted May 12, 2026
Patent 12612568
LINED VESSEL, COMPOSITE, AND PROCESS
2y 4m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
82%
With Interview (+9.0%)
2y 9m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 876 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month